Zuranolone

目录号: PL01379 纯度: ≥99%
Zuranolone 是一个口服有效的 GABAA 受体的神经活性类固醇正向变构调节剂, 对 α1β2γ2 和 α4β3δ GABAA 受体的 EC50 值分别为 296 和 163 nM。
CAS No. :1632051-40-1
商品编号 规格 价格 会员价 是否有货 数量
PL01379-2mg 2mg ¥803.00 请登录
PL01379-5mg 5mg ¥1446.00 请登录
PL01379-10mg 10mg ¥2410.00 请登录
PL01379-25mg 25mg ¥5143.00 请登录
PL01379-50mg 50mg ¥7956.00 请登录
PL01379-100mg 100mg ¥13581.00 请登录
PL01379-200mg 200mg 询价 询价
PL01379-500mg 500mg 询价 询价
PL01379-10mM*1mLinDMSO 10mM*1mLinDMSO ¥1592.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
Zuranolone
中文别名
1-(2-((3R,5R,8R,9R,10S,13S,14S,17S)-3-羟基-3,13-二甲基十六氢-1H-环戊二烯并[a]菲-17-基)-2-氧代乙基)-1H-吡唑-4-甲腈;舒拉诺龙SAGE-217
英文名称
Zuranolone
英文别名
SAGE-217;Zuranolone;7ZW49N180B;Zuranolone [INN];Zuranolone [USAN];Zuranolone (USAN/INN);AMY27908;BDBM50258216;WHO 10896;DB15490;D11793
Cas No.
1632051-40-1
分子式
C25H35N3O2
分子量
409.56
包装储存
Powder -20°C 3 years;4°C 2 years
详情描述
Zuranolone 是一个口服有效的 GABAA 受体的神经活性类固醇正向变构调节剂, 对 α1β2γ2 和 α4β3δ GABAA 受体的 EC50 值分别为 296 和 163 nM。
产品详情
Zuranolone 是一个口服有效的 GABAA 受体的神经活性类固醇正向变构调节剂, 对 α1β2γ2 和 α4β3δ GABAA 受体的 EC50 值分别为 296 和 163 nM。
生物活性
Zuranolone is an orally active and potent neuroactive steroid positive allosteric modulator of GABA A receptor, with EC 50 s of 296 and 163 nM for α 1 β 2 γ 2 and α 4 β 3 δ GABA A receptors, respectively.
性状
Solid
IC50 & Target[1][2]
EC50: 296 nM (α1β2γ2 GABAA receptor), 163 nM (α4β3δ GABAA receptor)
体外研究(In Vitro)
Zuranolone is a potent GABAA receptor agonist with EC50s of 296 and 163 nM for α1β2γ2 and α4β3δ GABAA receptors, respectively. Zuranolone is currently being studied in parallel phase 2 clinical trials for the treatment of postpartum depression (PPD) and major depressive disorder (MDD). Zuranolone shows >30 μM inhibition in a cardiac panel of eight relevant cardiac ion channels. At 10 μM concentration of Zuranolone, only binding at the glycine (57%), sigma receptors (88%), and inhibition of the transient receptor potential vanilloid 1 (TRPV1, 95%) is noted. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Acute administration of Zuranolone (0.3 to 10 mg/kg, ip) effectively reduces pentylenetretazol (PTZ)-induced seizures in mice (MEC plasma =85 nM) as well as produces a dose-dependent anticonvulsant effect in the mouse 6 Hz electrical stimulation model. In the rat model of status epilepticus (SE), Zuranolone (0.3 to 5 mg, iv) abolishes both behavioral and electrographic seizure activity, even when administered 60 min after induction of SE. Additional PK studies of Zuranolone in dog show low clearance (<10% of hepatic blood flow), resulting in excellent oral bioavailability (F=68%). has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Martinez Botella G, et al. Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1-yl)-19-nor-5β-pregnan-20-one: A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)A Receptor. J Med Che
溶解度数据
In Vitro: DMSO : 100 mg/mL (244.16 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble)配制储备液
搜索质检报告(COA)
[1]. Martinez Botella G, et al. Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1-yl)-19-nor-5β-pregnan-20-one: A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)A Receptor. J Med Che

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2